Literature DB >> 25451517

Comparison between mathematical models of intermittent androgen suppression for prostate cancer.

Takuma Hatano1, Yoshito Hirata2, Hideyuki Suzuki2, Kazuyuki Aihara2.   

Abstract

Mathematical modelling is essential for personalizing intermittent androgen suppression, which was proposed to delay the relapse of prostate cancer by stopping and resuming the hormone therapy repeatedly than adopting the conventional continuous androgen suppression, or normal hormonal therapy. Although there are several mathematical models for intermittent androgen suppression, the performances of these mathematical models have not been compared sufficiently. In this paper, we compare the Hirata-Bruchovsky-Aihara model with the Portz-Kuang-Nagy model, two recently proposed models for intermittent androgen suppression. We fitted these mathematical models to the actual data of 17 patients and examined the dynamical behavior and prediction accuracy of these models. Although we found no significant difference between these models in terms of prediction accuracy, the Portz-Kuang-Nagy model could not reproduce the relapse under the simulation condition assuming the continuous androgen suppression. Thus, the results suggest that the Hirata-Bruchovsky-Aihara model is more useful than the Portz-Kuang-Nagy model when we attempt to compare the therapeutic efficiencies of intermittent suppression and continuous androgen suppression.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Personalized treatment schedule

Mesh:

Substances:

Year:  2014        PMID: 25451517     DOI: 10.1016/j.jtbi.2014.10.034

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  1 in total

1.  Intermittent Androgen Suppression: Estimating Parameters for Individual Patients Based on Initial PSA Data in Response to Androgen Deprivation Therapy.

Authors:  Yoshito Hirata; Kai Morino; Koichiro Akakura; Celestia S Higano; Nicholas Bruchovsky; Teresa Gambol; Susan Hall; Gouhei Tanaka; Kazuyuki Aihara
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.